Market Cap 278.33M
Revenue (ttm) 45.15M
Net Income (ttm) -39.23M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -86.89%
Debt to Equity Ratio -0.98
Volume 110,500
Avg Vol 167,102
Day's Range N/A - N/A
Shares Out 61.31M
Stochastic %K 63%
Beta 0.56
Analysts Strong Sell
Price Target $9.20

Company Profile

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; an...

Industry: Medical Devices
Sector: Healthcare
Phone: 888 321 5212
Address:
6272 West 91st Avenue, Westminster, United States
Gunnar1
Gunnar1 May. 13 at 4:35 PM
$TLSI Starter for me here
0 · Reply
rapidtrades
rapidtrades May. 13 at 4:32 PM
$TLSI headed for recovery folks
0 · Reply
stklover
stklover May. 13 at 3:52 PM
$TLSI Maybe they should take that money they raised awhile ago and buy back their stock🤣
0 · Reply
rapidtrades
rapidtrades May. 13 at 3:39 PM
$TLSI Bouncing back up after lunch NY time
0 · Reply
stklover
stklover May. 13 at 3:01 PM
$TLSI Stock down 65% this year. I thought bottom was in on the previous quarter and I took a nice position. Now I get hammered. I’ll buy more here, wait about 3-days, and buy more then. Delay in FDA main reason why stock is down.
0 · Reply
Arcides
Arcides May. 13 at 2:49 PM
$TLSI Half of market cap gone...
0 · Reply
rapidtrades
rapidtrades May. 13 at 2:24 PM
$TLSI joined the party 🎉 bouncing back flat
1 · Reply
Investor6
Investor6 May. 13 at 2:22 PM
$TLSI Exaggeration to the downside.
0 · Reply
Golibajje
Golibajje May. 13 at 2:21 PM
$TLSI Watching! Might drop to $2.10.. will add there!
0 · Reply
HUBIE_DUBOIS
HUBIE_DUBOIS May. 13 at 1:59 PM
$TLSI Bought at 2.24
1 · Reply
Latest News on TLSI
TriSalus Life Sciences reports Q EPS 3c, one estimate (16c)

2026-05-12T22:14:02.000Z - 18 hours ago

TriSalus Life Sciences reports Q EPS 3c, one estimate (16c)


TriSalus Life Sciences Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 20 hours ago

TriSalus Life Sciences Earnings Call Transcript: Q1 2026


TriSalus announces journal publication of PEDD study

2026-05-12T16:00:15.000Z - 1 day ago

TriSalus announces journal publication of PEDD study


TriSalus Life Sciences Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 2 months ago

TriSalus Life Sciences Earnings Call Transcript: Q4 2025


TriSalus Life Sciences reports Q4 EPS (21c), consensus (14c)

2026-03-05T21:05:24.000Z - 2 months ago

TriSalus Life Sciences reports Q4 EPS (21c), consensus (14c)


TriSalus Life Sciences Proposes Public Offering

Feb 19, 2026, 4:01 PM EST - 2 months ago

TriSalus Life Sciences Proposes Public Offering


TriSalus Life Sciences appoints Stansky to board of directors

2026-02-09T14:10:56.000Z - 3 months ago

TriSalus Life Sciences appoints Stansky to board of directors


TriSalus Life Sciences named a 2026 Top Pick at Northland

2026-01-08T14:35:32.000Z - 4 months ago

TriSalus Life Sciences named a 2026 Top Pick at Northland


TriSalus Life Sciences Transcript: KOL Event

Dec 15, 2025, 2:00 PM EST - 5 months ago

TriSalus Life Sciences Transcript: KOL Event


TriSalus Life Sciences files $150M mixed securities shelf

2025-11-13T21:46:39.000Z - 6 months ago

TriSalus Life Sciences files $150M mixed securities shelf


TriSalus Life Sciences Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 6 months ago

TriSalus Life Sciences Earnings Call Transcript: Q3 2025


TriSalus Life Sciences reports Q3 EPS (96c) vs (12c) last year

2025-11-13T21:05:42.000Z - 6 months ago

TriSalus Life Sciences reports Q3 EPS (96c) vs (12c) last year


TriSalus Life Sciences Transcript: KOL Event

Nov 12, 2025, 10:00 AM EST - 6 months ago

TriSalus Life Sciences Transcript: KOL Event


TriSalus Life Sciences Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 9 months ago

TriSalus Life Sciences Earnings Call Transcript: Q2 2025


TriSalus Life Sciences reports Q2 EPS (27c), consensus (22c)

2025-08-12T20:05:58.000Z - 9 months ago

TriSalus Life Sciences reports Q2 EPS (27c), consensus (22c)


TriSalus Life Sciences backs FY25 revenue growth view up 50%

2025-08-12T20:05:51.000Z - 9 months ago

TriSalus Life Sciences backs FY25 revenue growth view up 50%


TriSalus Life Sciences Earnings Call Transcript: Q1 2025

May 15, 2025, 8:00 AM EDT - 1 year ago

TriSalus Life Sciences Earnings Call Transcript: Q1 2025


TriSalus Life Sciences Earnings Call Transcript: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

TriSalus Life Sciences Earnings Call Transcript: Q4 2024


TriSalus Life Sciences Earnings Call Transcript: Q3 2024

Nov 14, 2024, 9:00 AM EST - 1 year ago

TriSalus Life Sciences Earnings Call Transcript: Q3 2024


TriSalus Life Sciences Earnings Call Transcript: Q2 2024

Aug 15, 2024, 9:00 AM EDT - 1 year ago

TriSalus Life Sciences Earnings Call Transcript: Q2 2024


Gunnar1
Gunnar1 May. 13 at 4:35 PM
$TLSI Starter for me here
0 · Reply
rapidtrades
rapidtrades May. 13 at 4:32 PM
$TLSI headed for recovery folks
0 · Reply
stklover
stklover May. 13 at 3:52 PM
$TLSI Maybe they should take that money they raised awhile ago and buy back their stock🤣
0 · Reply
rapidtrades
rapidtrades May. 13 at 3:39 PM
$TLSI Bouncing back up after lunch NY time
0 · Reply
stklover
stklover May. 13 at 3:01 PM
$TLSI Stock down 65% this year. I thought bottom was in on the previous quarter and I took a nice position. Now I get hammered. I’ll buy more here, wait about 3-days, and buy more then. Delay in FDA main reason why stock is down.
0 · Reply
Arcides
Arcides May. 13 at 2:49 PM
$TLSI Half of market cap gone...
0 · Reply
rapidtrades
rapidtrades May. 13 at 2:24 PM
$TLSI joined the party 🎉 bouncing back flat
1 · Reply
Investor6
Investor6 May. 13 at 2:22 PM
$TLSI Exaggeration to the downside.
0 · Reply
Golibajje
Golibajje May. 13 at 2:21 PM
$TLSI Watching! Might drop to $2.10.. will add there!
0 · Reply
HUBIE_DUBOIS
HUBIE_DUBOIS May. 13 at 1:59 PM
$TLSI Bought at 2.24
1 · Reply
BoomTradesBio
BoomTradesBio May. 13 at 1:54 PM
$TLSI Took some
0 · Reply
stockanalysis_
stockanalysis_ May. 13 at 1:45 PM
Losers Today: $WOK $RVPH $TLSI $IDN $HTCO Download this screener: https://stockanalysis.com/markets/losers/?ref=saveontrading
0 · Reply
OpenOutcrier
OpenOutcrier May. 13 at 12:31 PM
$TLSI (-12.1% pre) TriSalus lowers 2026 revenue guidance to $54-57 million https://ooc.bz/l/102109
0 · Reply
MarketBeat
MarketBeat May. 13 at 2:08 AM
https://marketbeat.com/a/8651232/ $TLSI TriSalus Life Sciences Q1 Earnings Call Highlights
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 12 at 8:10 PM
$TLSI Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.03 up 107.69% YoY • Reported revenue of $8.9M down -2.92% YoY • TriSalus Life Sciences revised its 2026 revenue guidance to $54M to $57M, reflecting the impact of commercial expansion and the timing of FDA clearance for TriNav Advance.
0 · Reply
BioTuesdays
BioTuesdays May. 5 at 7:40 PM
$TLSI has initiated patient enrollment for its PREDICTT clinical trial designed to evaluate its novel Pressure-Enabled Drug Delivery (PEDD) approach in patients with primary or metastatic liver tumors. https://biotuesdays.com/2026/05/05/trisalus-launches-trial-evaluating-pressure-enabled-drug-delivery-in-liver-tumors/
0 · Reply
focafoca99
focafoca99 May. 5 at 12:37 AM
$TLSI started enrollment for the PREDICTT trial testing its Pressure-Enabled Drug Delivery system in liver tumors.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 24 at 7:14 PM
$TLSI RSI: 72.07, MACD: 0.0815 Vol: 0.28, MA20: 4.30, MA50: 4.44 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
AccuRoger
AccuRoger Apr. 13 at 12:39 PM
$TLSI This presentation is scheduled for tomorrow at SIR. Quote Dominant fibroid volume reduction ranged from 69% to 89%, which compares favorably with previously reported reductions (42%-58%). Conclusion: The PEDD microcatheter demonstrates a compelling combination of safety, efficacy, and procedural efficiency for symptomatic uterine fibroids. https://www.sirmeeting.org/agenda.asp?BCFO=&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1
0 · Reply
focafoca99
focafoca99 Apr. 10 at 12:19 AM
$TLSI is heading into SIR 2026 with new clinical and preclinical PEDD platform data across multiple tumor types.
0 · Reply
AccuRoger
AccuRoger Apr. 8 at 8:59 PM
$TLSI This human trial report was published today. It is small, with powerful results. Enjoy. Quote: Treatment response in the PEDD versus EH groups was complete response 22% vs 0%, partial response 61% vs 64%, stable disease 6% vs 7%, progressive disease 0% vs 29% and overall response 83% vs 64%. P-value for all response data was 0.034, and for ORR was 0.044 (Chi Squared analysis). https://www.jvir.org/article/S1051-0443(26)00115-6/fulltext
0 · Reply
AccuRoger
AccuRoger Mar. 18 at 12:41 PM
$TLSI This is a human trial in progress. The abstract is embargoed at the moment. FYI
0 · Reply